Nahdi Medical Company
TADAWUL:4164.SR
132.8 (SAR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 909.662 | 1,076.312 | 401.044 | 1,008.53 | 372.354 | 170.073 | 121.235 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 202.832 | 200.359 | 0 |
| Cash and Short Term Investments
| 909.662 | 1,076.312 | 401.044 | 1,008.53 | 575.185 | 370.433 | 121.235 |
| Net Receivables
| 433.502 | 130.202 | 140.283 | 152.937 | 188.095 | 144.086 | 150.432 |
| Inventory
| 1,409.409 | 1,182.835 | 1,116.482 | 1,220.36 | 1,203.148 | 1,184.211 | 1,247.964 |
| Other Current Assets
| 6.17 | 174.293 | 141.566 | 44.955 | 33.156 | 163.102 | 230.794 |
| Total Current Assets
| 2,758.744 | 2,563.641 | 1,799.376 | 2,426.781 | 1,999.584 | 1,861.832 | 1,750.426 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 2,307.109 | 2,080.395 | 2,213.258 | 2,018.815 | 1,951.581 | 582.986 | 762.784 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 51.171 | 47.061 | 44.206 | 41.364 | 35.08 | 40.119 | 44.565 |
| Goodwill and Intangible Assets
| 51.171 | 47.061 | 44.206 | 41.364 | 35.08 | 40.119 | 44.565 |
| Long Term Investments
| 254.304 | 253.806 | 230.085 | 179 | 193 | 194.894 | 0 |
| Tax Assets
| -254.304 | -253.806 | -230.085 | -179 | 0 | 0 | 0 |
| Other Non-Current Assets
| 254.304 | 253.806 | 230.085 | 179 | 7.227 | 9.018 | 13.704 |
| Total Non-Current Assets
| 2,612.584 | 2,381.262 | 2,487.549 | 2,239.178 | 2,186.888 | 827.017 | 821.054 |
| Total Assets
| 5,371.327 | 4,944.903 | 4,286.925 | 4,665.959 | 4,186.472 | 2,688.849 | 2,571.479 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 894.308 | 637.166 | 483.995 | 440.257 | 520.955 | 459.621 | 457.589 |
| Short Term Debt
| 304.189 | 375.874 | 367.415 | 406.126 | 233.227 | 37.056 | 30.636 |
| Tax Payables
| 112.532 | 106.548 | 5.234 | 98.054 | 78.44 | 37.056 | 30.636 |
| Deferred Revenue
| 405.841 | 338.98 | 308.335 | 37.505 | 35.306 | 24.792 | 27.753 |
| Other Current Liabilities
| 26.757 | 156.362 | 126.116 | 530.469 | 459.343 | 344.378 | 300.629 |
| Total Current Liabilities
| 1,631.095 | 1,508.382 | 1,285.861 | 1,414.357 | 1,248.831 | 865.847 | 816.607 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 870.566 | 792.23 | 991.642 | 828.953 | 984.41 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 1.545 | 1.545 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 406.91 | 400.906 | 405.826 | 343.869 | 168.829 | 142.57 | 125.857 |
| Total Non-Current Liabilities
| 1,277.477 | 1,193.137 | 1,397.468 | 1,172.822 | 1,153.239 | 144.115 | 127.402 |
| Total Liabilities
| 2,908.571 | 2,701.519 | 2,683.329 | 2,587.179 | 2,402.07 | 1,009.962 | 944.009 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 1,300 | 1,300 | 1,300 | 1,000 | 50 | 50 | 50 |
| Retained Earnings
| 794.391 | 663.833 | 112.616 | 969.03 | 1,709.403 | 1,603.886 | 1,552.471 |
| Accumulated Other Comprehensive Income/Loss
| 368.365 | 279.551 | 190.98 | 109.75 | 25 | 25 | 25 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Shareholders Equity
| 2,462.756 | 2,243.384 | 1,603.595 | 2,078.781 | 1,784.403 | 1,678.886 | 1,627.471 |
| Total Equity
| 2,462.756 | 2,243.384 | 1,603.595 | 2,078.781 | 1,784.403 | 1,678.886 | 1,627.471 |
| Total Liabilities & Shareholders Equity
| 5,371.327 | 4,944.903 | 4,286.925 | 4,665.959 | 4,186.472 | 2,688.849 | 2,571.479 |